710
Views
44
CrossRef citations to date
0
Altmetric
Original Article

Nano-sized zinc oxide and silver, but not titanium dioxide, induce innate and adaptive immunity and antiviral response in differentiated THP-1 cells

, , , , , , , , , , ORCID Icon, & ORCID Icon show all
Pages 936-951 | Received 01 Jun 2017, Accepted 18 Sep 2017, Published online: 29 Sep 2017

References

  • Ablasser, A., and V. Hornung. 2011. “Where, in Antiviral Defense, Does IFIT1 Fit?” Nature Immunology 12: 588–590.
  • Asharani, P. V., G. Low Kah Mun, M. P. Hande, and S. Valiyaveettil. 2009. “Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human Cells.” ACS Nano 3: 279–290.
  • Cassel, S. L., S. C. Eisenbarth, S. S. Iyer, J. J. Sadler, O. R. Colegio, L. A. Tephly, A. B. Carter, P. B. Rothman, R. A. Flavell, and F. S. Sutterwala. 2008. “The Nalp3 Inflammasome is Essential for the Development of Silicosis.” Proceedings of the National Academy of Sciences of the United States of America 105: 9035–9040.
  • DeLoid, G. M., J. M. Cohen, G. Pyrgiotakis, and P. Demokritou. 2017. “Preparation, Characterization, and in Vitro Dosimetry of Dispersed, Engineered Nanomaterials.” Nature Protocols 12: 355–371.
  • Deng, Z. J., M. Liang, M. Monteiro, I. Toth, and R. F. Minchin. 2011. “Nanoparticle-induced Unfolding of Fibrinogen Promotes Mac-1 Receptor Activation and Inflammation.” Nature Nanotechnology 6: 39–44.
  • Diamond, M. S., and M. Farzan. 2013. “The Broad-Spectrum Antiviral Functions of IFIT and IFITM Proteins.” Nature Reviews. Immunology 13: 46–57.
  • Gliga, A. R., S. Skoglund, I. O. Wallinder, B. Fadeel, and H. L. Karlsson. 2014. “Size-Dependent Cytotoxicity of Silver Nanoparticles in Human Lung Cells: The Role of Cellular Uptake, Agglomeration and Ag Release.” Particle and Fibre Toxicology 11: 11.
  • Gojova, A., B. Guo, R. S. Kota, J. C. Rutledge, I. M. Kennedy, and A. I. Barakat. 2007. “Induction of Inflammation in Vascular Endothelial Cells by Metal Oxide Nanoparticles: Effect of Particle Composition.” Environmental Health Perspectives 115: 403–409.
  • Hanley, C., A. Thurber, C. Hanna, A. Punnoose, J. Zhang, and D. G. Wingett. 2009. “The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction.” Nanoscale Research Letters 4: 1409–1420.
  • He, Z., and P. Alexandridis. 2015. “Nanoparticles in Ionic Liquids: Interactions and Organization.” Physical Chemistry Chemical Physics 17: 18238–18261.
  • Hornung, V., F. Bauernfeind, A. Halle, E. O. Samstad, H. Kono, K. L. Rock, K. A. Fitzgerald, and E. Latz. 2008. “Silica Crystals and Aluminum Salts Activate the NALP3 Inflammasome Through Phagosomal Destabilization.” Nature Immunology 9: 847–856.
  • Hsiao, I. L., Y. K. Hsieh, C. F. Wang, I. C. Chen, and Y. J. Huang. 2015. “Trojan-Horse Mechanism in the Cellular Uptake of Silver Nanoparticles Verified by Direct Intra- and Extracellular Silver Speciation Analysis.” Environmental Science & Technology 49: 3813–3821.
  • Jo, E. K., J. K. Kim, D. M. Shin, and C. Sasakawa. 2016. “Molecular Mechanisms Regulating NLRP3 Inflammasome Activation.” Cellular & Molecular Immunology 13: 148–159.
  • Johnson, W. E., C. Li, and A. Rabinovic. 2007. “Adjusting Batch Effects in Microarray Expression Data Using Empirical Bayes Methods.” Biostatistics 8: 118–127.
  • Kallio, M. A., J. T. Tuimala, T. Hupponen, P. Klemela, M. Gentile, I. Scheinin, M. Koski, J. Kaki, and E. I. Korpelainen. 2011. “Chipster: User-friendly Analysis Software for Microarray and Other High-throughput Data.” BMC Genomics 12: 507.
  • Kimura, T., and T. Kambe. 2016. “The Functions of Metallothionein and ZIP and ZnT Transporters: An Overview and Perspective.” International Journal of Molecular Sciences 17: 336.
  • Krizkova, S., M. Kepinska, G. Emri, M. A. Rodrigo, K. Tmejova, D. Nerudova, R. Kizek, and V. Adam. 2016. “Microarray Analysis of Metallothioneins in Human Diseases—A review.” Journal of Pharmaceutical and Biomedical Analysis 117: 464–473.
  • Kruszewski, M., K. Brzoska, G. Brunborg, N. Asare, M. Dobrzynska, M. Dusinska, L. M. Fjellsbo, et al. 2011. “Toxicity of Silver Nanomaterials in Higher Eukaryotes.” Advances in Molecular Toxicology 5: 179–218.
  • Leavy, O. 2011. “Vaccines: Dual TLR Hit for Vaccine Success.” Nature Reviews Immunology 11: 234–235.
  • Lopes, S., C. Pinheiro, A. M. Soares, and S. Loureiro. 2016. “Joint Toxicity Prediction of Nanoparticles and Ionic Counterparts: Simulating Toxicity Under a Fate Scenario.” Journal of Hazardous Materials 320: 1–9.
  • Ma, H., P. L. Williams, and S. A. Diamond. 2013. “Ecotoxicity of Manufactured ZnO Nanoparticles: A Review.” Environmental Pollution (Barking, Essex : 1987) 172: 76–85.
  • Mcdermott, J. E., M. Archuleta, B. D. Thrall, J. N. Adkins, and K. M. Waters. 2011. “Controlling the Response: Predictive Modeling of a Highly Central, Pathogen-Targeted Core Response Module in Macrophage Activation.” PLoS One 6: e14673.
  • Nowack, B., H. F. Krug, and M. Height. 2011. “120 Years of Nanosilver History: Implications for Policy Makers.” Environmental Science & Technology 45: 1177–1183.
  • Oliveros, J. C. 2007–2015. Venny. An Interactive Tool for Comparing Lists with Venn's Diagrams. http://bioinfogp.cnb.csic.es/tools/venny/index.html.
  • Palomaki, J., E. Valimaki, J. Sund, M. Vippola, P. A. Clausen, K. A. Jensen, K. Savolainen, S. Matikainen, and H. Alenius. 2011. “Long, Needle-like Carbon Nanotubes and Asbestos Activate the NLRP3 Inflammasome Through a Similar Mechanism.” ACS Nano 5: 6861–6870.
  • Pichlmair, A., C. Lassnig, C. A. Eberle, M. W. Gorna, C. L. Baumann, T. R. Burkard, T. Burckstummer, et al. 2011. “IFIT1 is an Antiviral Protein that Recognizes 5'-Triphosphate RNA.” Nature Immunology 12: 624–630.
  • Qin, Z. 2012. “The Use of THP-1 Cells as a Model for Mimicking the Function and Regulation of Monocytes and Macrophages in the Vasculature.” Atherosclerosis 221: 2–11.
  • Ritchie, M. E., B. Phipson, D. Wu, Y. Hu, C. W. Law, W. Shi, and G. K. Smyth. 2015. “Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies.” Nucleic Acids Research 43: e47.
  • Roy, R., M. Das, and P. D. Dwivedi. 2015. “Toxicological Mode of Action of ZnO Nanoparticles: Impact on Immune Cells.” Molecular Immunology 63: 184–192.
  • Sharma, V. K., K. M. Siskova, R. Zboril, and J. L. Gardea-Torresdey. 2014. “Organic-coated Silver Nanoparticles in Biological and Environmental Conditions: Fate, Stability and Toxicity.” Advances in Colloid and Interface Science 204: 15–34.
  • Shi, H., R. Magaye, V. Castranova, and J. Zhao. 2013. “Titanium Dioxide Nanoparticles: A Review of Current Toxicological Data.” Particle and Fibre Toxicology 10: 15
  • Tuli, H. S., D. Kashyap, S. K. Bedi, P. Kumar, G. Kumar, and S. S. Sandhu. 2015. “Molecular Aspects of Metal Oxide Nanoparticle (MO-NPs) Mediated Pharmacological Effects.” Life Science 143: 71–79.
  • Tuomela, S., R. Autio, T. Buerki-Thurnherr, O. Arslan, A. Kunzmann, B. Andersson-Willman, P. Wick, et al. 2013. “Gene Expression Profiling of Immune-competent Human Cells Exposed to Engineered Zinc Oxide or Titanium Dioxide Nanoparticles.” PLoS One 8: e68415.
  • Tyanova, S., T. Temu, P. Sinitcyn, A. Carlson, M. Y. Hein, T. Geiger, M. Mann, and J. Cox. 2016. “The Perseus Computational Platform for Comprehensive Analysis of (prote)omics Data.” Nature Methods 13: 731–740.
  • Utembe, W., K. Potgieter, A. B. Stefaniak, and M. Gulumian. 2015. “Dissolution and Biodurability: Important Parameters Needed for Risk Assessment of Nanomaterials.” Particle and Fibre Toxicology 12: 11
  • Weber, K., and J. D. Schilling. 2014. “Lysosomes Integrate Metabolic-inflammatory Cross-talk in Primary Macrophage Inflammasome Activation.” Journal of Biological Chemistry 289: 9158–9171.
  • Yang, E. J., S. Kim, J. S. Kim, and I. H. Choi. 2012. “Inflammasome Formation and IL-1beta Release by Human Blood Monocytes in Response to Silver Nanoparticles.” Biomaterials 33: 6858–6867.
  • Zhang, X. F., W. Shen, and S. Gurunathan. 2016. “Silver Nanoparticle-Mediated Cellular Responses in Various Cell Lines: An in Vitro Model.” International Journal of Molecular Sciences 17: 1603. doi:10.3390/ijms17101603

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.